CN112220714A - Red ginseng vigor activating oxygen eye cream and preparation method thereof - Google Patents

Red ginseng vigor activating oxygen eye cream and preparation method thereof Download PDF

Info

Publication number
CN112220714A
CN112220714A CN202010954426.6A CN202010954426A CN112220714A CN 112220714 A CN112220714 A CN 112220714A CN 202010954426 A CN202010954426 A CN 202010954426A CN 112220714 A CN112220714 A CN 112220714A
Authority
CN
China
Prior art keywords
phase
solution
red ginseng
eye cream
percent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010954426.6A
Other languages
Chinese (zh)
Inventor
陈娟
阳综业
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Duomei Biotechnology Co ltd
Original Assignee
Guangzhou Duomei Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Duomei Biotechnology Co ltd filed Critical Guangzhou Duomei Biotechnology Co ltd
Priority to CN202010954426.6A priority Critical patent/CN112220714A/en
Publication of CN112220714A publication Critical patent/CN112220714A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/927Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses red ginseng vigor activating oxygen eye cream and a preparation method thereof, and the red ginseng vigor activating oxygen eye cream comprises water, methyl propylene glycol, glycerol, hyaluronic acid, EDTA disodium, methyl ester, glyceryl polyether-26, PEG/PPG-17/6 copolymer, red ginseng extract, carnosine, dipalmitoyl hydroxyproline, glyceryl glucoside, chicory tiramer, a compound anti-allergy agent, essence, phenoxyethanol/chlorphenesin and the like. The invention has excellent moisturizing performance, and can effectively fade fine lines and black eye circles.

Description

Red ginseng vigor activating oxygen eye cream and preparation method thereof
Technical Field
The invention relates to the field of eye cream production and preparation, and particularly relates to red ginseng vigor activating oxygen eye cream and a preparation method thereof.
Background
The eye cream is one of skin care cosmetics and has the function of moistening eye skin. The eye mask can reduce the problems of dark circles and under-eye bags, and also has the effect of improving wrinkles and fine lines. The eye cream is used for protecting the thin skin around the eyes, has certain effects on pouches, black eye circles, crow's feet and the like, but different eye creams have different effects and are divided into moisturizing eye cream, firming eye cream, anti-aging eye cream, anti-allergy eye cream and the like in terms of functions.
The existing eye cream has poor moisturizing performance, and has common effects of fading fine lines and fading black eye circles. It is still difficult to meet the requirements of people. In view of the above, the present invention is particularly proposed.
Disclosure of Invention
The invention aims to design red ginseng original qi oxygen activating eye cream and a preparation method thereof, so that the red ginseng original qi oxygen activating eye cream has excellent moisturizing performance, and can effectively lighten fine lines and black eyes.
In order to achieve the purpose, the invention provides the following technical scheme:
red ginseng original qi oxygen activating eye cream is prepared from the following raw materials in percentage by weight:
phase A: water 31.05-68.43%, preferably 64.01%; 4-5%, preferably 4%; 2-5% of glycerol, preferably 2%; hyaluronic acid 0.01-0.05%, preferably 0.02%; disodium EDTA 0.01-0.05%, preferably 0.02%; methyl ester 0.1-0.2%, preferably 0.2%; glyceryl polyether-262-5%, preferably 3%; PEG/PPG-17/6 copolymer 0.5-3%, preferably 1%;
phase B: 2-4% of emulsifier A, preferably 2.5%; 0.5-1% of emulsifier B, preferably 0.5%; beeswax 0.5-1%, preferably 0.8%; GMS 30SE 0.5-1.5%, preferably 1.2%; 0.3-1% of 16\18 alcohol, preferably 0.4%; propyl ester 0.1-0.15%, preferably 0.1%; 0.5-1% of shea butter, preferably 0.5%; 0.5-1% of silicone oil A, preferably 0.5%; 0.5-1%, preferably 0.5%; 3-5%, preferably 3%; 2-5% of macadamia nut oil, preferably 2%; 2-5%, preferably 3%; 2-5% of silicone oil B, preferably 3%;
and C phase: sodium acrylate/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate-801-2%, preferably 1%;
phase D: 0.5-2%, preferably 0.6%; carnosine 0.2-0.5%, preferably 0.2%; dipalmitoyl hydroxyproline 1-3%, preferably 1%; 3-6% of water, preferably 3%;
phase E: 0.5-2% of glycerol glucoside, preferably 0.5%; chicory tiramer 0.5-2%, preferably 0.5%; 0.5-1% of composite anti-allergic agent, preferably 0.5%; 0.05 to 0.1 percent of essence, preferably 0.1 percent; 0.3 to 0.4 percent of phenoxyethanol/chlorphenesin, preferably 0.35 percent.
Further, silicone oil A in phase B is polydimethylsiloxane, silicone oil B is cyclopentadimethylsiloxane/cyclohexasiloxane, beeswax is beeswax 8044, emulsifier A is M68 emulsifier, and emulsifier B is A165 emulsifier.
Further, the water in the A phase and the D phase is deionized water.
The preparation method of the red ginseng vigor activating oxygen eye cream comprises the following steps:
step 1: proportioning raw materials of the phase A, the phase B, the phase C, the phase D and the phase E;
step 2: mixing, dispersing and stirring the phase D raw material uniformly to obtain a solution A;
step 2: putting the phase A raw material into a vacuum homogenizing emulsifying pot, starting stirring at the rotating speed of 60rpm, heating to 85-90 ℃, continuously stirring and preserving heat for 5-8min to obtain a solution B;
and step 3: putting the phase B raw material into an oil phase pot, starting stirring at the rotating speed of 40rpm, heating to 80-85 ℃, continuously stirring and preserving heat for 5-8min to completely dissolve the raw material to obtain a solution C;
and 4, step 4: opening the vacuum homogenizing emulsifying pot in the step 2 to be vacuum, starting stirring, rotating at the speed of 60rpm, pumping the solution C obtained in the step 3 into the vacuum homogenizing emulsifying pot, mixing the solution C with the solution B, opening the vacuum homogenizing emulsifying pot to be homogenized at the speed of 2800rpm, homogenizing for 5min, stirring at the speed of 30rpm, preserving heat, stirring for 8-10min, and then cooling to obtain a solution D;
and 5: cooling the solution D obtained in the step 4 to 60 ℃, adding the phase C raw material into a vacuum homogenizing emulsifying pot, mixing the phase C raw material with the solution D, starting homogenizing at the rotating speed of 2500rpm for 2min, and continuously stirring and cooling to obtain a solution E;
step 6: cooling the solution E obtained in the step 5 to 45 ℃, then adding the solution A and the E-phase raw material obtained in the step 1, and continuously stirring for 20-30min to obtain a solution F:
and 7: and (4) sampling and detecting the solution F obtained in the step (6), and filtering and discharging after the solution F is qualified.
Further, the detection in step 7 includes appearance detection, viscosity detection, pH value detection, heat resistance detection, cold resistance detection and centrifugation detection.
Compared with the prior art, the invention has the beneficial effects that:
the red ginseng is a cooked product of ginseng and has the effects of greatly tonifying primordial qi, recovering pulse, relieving depletion, benefiting qi and controlling blood. In clinic, the red ginseng extract can be applied to improve the related functions of the human body, particularly to regulate blood pressure, resist fatigue, calm the nerves, supplement the brain and the like. From the above-mentioned functions, the health value of red ginseng is very high. Because the red reference ginseng has larger potency of medicine, the warm and dry property is larger, and the dosage is a little less than that of the common ginseng.
In the eye cream production process, based on long-term continuous experimental data, the red ginseng extract is added in a reasonable amount, and the addition amounts of other raw materials are correspondingly and reasonably adjusted. The eye cream has excellent moisturizing performance, and can effectively fade fine lines and black eye circles.
Detailed Description
Examples 1 to 3:
red ginseng original qi oxygen activating eye cream of examples 1-3 was prepared according to the following raw materials in the following table 1 by weight percent, respectively.
Table 1:
Figure RE-GDA0002786227670000041
Figure RE-GDA0002786227670000051
wherein, the red ginseng original qi oxygen activating eye cream prepared in the following modes of example 1-3 respectively:
example 1:
step 1: proportioning raw materials of the phase A, the phase B, the phase C, the phase D and the phase E;
step 2: mixing, dispersing and stirring the phase D raw material uniformly to obtain a solution A;
step 2: putting the phase A raw material into a vacuum homogenizing emulsifying pot, starting stirring, rotating at the speed of 60rpm, heating to 85 ℃, continuously stirring and preserving heat for 5min to obtain a solution B;
and step 3: putting the phase B raw material into an oil phase pot, starting stirring, rotating at 40rpm, heating to 80 ℃, continuously stirring and preserving heat for 5min to completely dissolve the raw material to obtain a solution C;
and 4, step 4: opening the vacuum homogenizing emulsifying pot in the step 2 to vacuum, starting stirring at a rotating speed of 60rpm, pumping the solution C obtained in the step 3 into the vacuum homogenizing emulsifying pot, mixing the solution C with the solution B, opening the vacuum homogenizing emulsifying pot to homogenize at a rotating speed of 2800rpm for 5min, stirring at a rotating speed of 30rpm, preserving heat, stirring for 8min, and then cooling to obtain a solution D;
and 5: cooling the solution D obtained in the step 4 to 60 ℃, adding the phase C raw material into a vacuum homogenizing emulsifying pot, mixing the phase C raw material with the solution D, starting homogenizing at the rotating speed of 2500rpm for 2min, and continuously stirring and cooling to obtain a solution E;
step 6: cooling the solution E obtained in the step 5 to 45 ℃, then adding the solution A obtained in the step 1 and the phase E raw material, and continuously stirring for 20min to obtain a solution F:
and 7: and (4) sampling and detecting the solution F obtained in the step (6), and filtering and discharging after the solution F is qualified.
Example 2:
step 1: proportioning raw materials of the phase A, the phase B, the phase C, the phase D and the phase E;
step 2: mixing, dispersing and stirring the phase D raw material uniformly to obtain a solution A;
step 2: putting the phase A raw material into a vacuum homogenizing emulsifying pot, starting stirring, rotating at 60rpm, heating to 88 ℃, continuously stirring, and keeping the temperature for 5-8min to obtain a solution B;
and step 3: putting the phase B raw material into an oil phase pot, starting stirring, rotating speed of 40rpm, heating to 83 ℃, continuously stirring and keeping the temperature for 6min to completely dissolve the raw material to obtain a solution C;
and 4, step 4: opening the vacuum homogenizing emulsifying pot in the step 2 to vacuum, starting stirring at a rotating speed of 60rpm, pumping the solution C obtained in the step 3 into the vacuum homogenizing emulsifying pot, mixing the solution C with the solution B, opening the vacuum homogenizing emulsifying pot to homogenize at a rotating speed of 2800rpm for 5min, stirring at a rotating speed of 30rpm, preserving heat, stirring for 9min, and then cooling to obtain a solution D;
and 5: cooling the solution D obtained in the step 4 to 60 ℃, adding the phase C raw material into a vacuum homogenizing emulsifying pot, mixing the phase C raw material with the solution D, starting homogenizing at the rotating speed of 2500rpm for 2min, and continuously stirring and cooling to obtain a solution E;
step 6: cooling the solution E obtained in the step 5 to 45 ℃, then adding the solution A obtained in the step 1 and the phase E raw material, and continuously stirring for 25min to obtain a solution F:
and 7: and (4) sampling and detecting the solution F obtained in the step (6), and filtering and discharging after the solution F is qualified.
Example 3:
step 1: proportioning raw materials of the phase A, the phase B, the phase C, the phase D and the phase E;
step 2: mixing, dispersing and stirring the phase D raw material uniformly to obtain a solution A;
step 2: putting the phase A raw material into a vacuum homogenizing emulsifying pot, starting stirring, rotating at the speed of 60rpm, heating to 90 ℃, continuously stirring and preserving heat for 8min to obtain a solution B;
and step 3: putting the phase B raw material into an oil phase pot, starting stirring at the rotating speed of 40rpm, heating to 85 ℃, continuously stirring and preserving heat for 8min to completely dissolve the raw material to obtain a solution C;
and 4, step 4: opening the vacuum homogenizing emulsifying pot in the step 2 to vacuum, starting stirring at a rotating speed of 60rpm, pumping the solution C obtained in the step 3 into the vacuum homogenizing emulsifying pot, mixing the solution C with the solution B, opening the vacuum homogenizing emulsifying pot to homogenize at a rotating speed of 2800rpm for 5min, stirring at a rotating speed of 30rpm, keeping the temperature and stirring for 8-10min, and then, starting cooling to obtain a solution D;
and 5: cooling the solution D obtained in the step 4 to 60 ℃, adding the phase C raw material into a vacuum homogenizing emulsifying pot, mixing the phase C raw material with the solution D, starting homogenizing at the rotating speed of 2500rpm for 2min, and continuously stirring and cooling to obtain a solution E;
step 6: cooling the solution E obtained in the step 5 to 45 ℃, then adding the solution A and the E-phase raw material obtained in the step 1, and continuously stirring for 30min to obtain a solution F:
and 7: and (4) sampling and detecting the solution F obtained in the step (6), and filtering and discharging after the solution F is qualified.
Experimental example 1:
the red ginseng original qi activating oxygen eye cream products prepared in examples 1-3 were tested and compared. The detection items comprise appearance detection, viscosity detection, pH value detection, heat resistance detection, cold resistance detection and centrifugation detection. The detection results are shown in table 2:
wherein, the appearance detection detects whether the product appearance is white paste or not; detecting whether the viscosity of the product meets 60000 +/-1000 by viscosity detection; detecting whether the pH value of the product meets 7.2 +/-0.5 by pH value detection; the heat resistance detection detects that the product is put into a constant temperature box at 40 +/-1 ℃ for 24H, then is taken out and recovered to room temperature, and is compared with a standard sample to observe whether the material body is not obviously different; cold resistance detection is carried out to detect whether the product is placed in a refrigerator for 24H at minus 8 +/-2 ℃, then the product is taken out and recovered to room temperature, and the room temperature is compared with a standard sample, and whether the material body is not obviously different is observed; centrifugal test the product was spun in a centrifuge at 2000rpm for 30min and observed for lack of stratification.
TABLE 2
Detecting items Example 1 Example 2 Example 3
Appearance detection Qualified Qualified Qualified
Viscosity detection Qualified Qualified Qualified
pH value detection Qualified Qualified Qualified
Heat resistance detection Qualified Qualified Qualified
Cold resistance detection Qualified Qualified Qualified
Centrifugal assay Qualified Qualified Qualified
As can be seen from Table 1, examples 1-3 all satisfied the test requirements, and it was confirmed that the formulation and the preparation method of the present invention both satisfied the product requirements.
Experimental example 2:
the red ginseng original oxygen-activating eye cream prepared in example 1 was subjected to a skin elasticity index test. The experimental conditions are as follows: 40 women, age 30-50 years old, volunteers. The experimental steps are as follows: the skin elasticity CotomerMPA 580 host manufactured by Courage + Khazaka, Germany, was used as a probe for a Reviscometer RV600 elasto-fibrous tissue test probe, and the average was taken five times. Test area: the skin around the eyes. Blank values (R2, R5, R7) of 20min after cleaning of the tested area are measured, and then the tested area is provided with skin elasticity indexes R2, R5 and R7 values (the negative pressure is constant at 450mbar in the test process) after the tested area is subjected to the test article by the subjects for keeping the test articles in use for 1 week, 2 weeks, 3 weeks and 4 weeks every day.
Specification of indexes: the closer the skin elasticity indexes R2, R5, R7 are to 1, the better the elasticity of the skin.
R2=Ua/Uf;R5=Ur/Ue;R7=Ur/Uf
Uf — maximum skin stretch;
ue — the amount of stretching of the skin at 0.1 second after constant negative pressure is applied to the skin, the amount of stretching of the elastic portion is located;
ur-after negative pressure is eliminated, the skin can quickly recover to the original state, and the skin is also divided into an elastic part value Ur, namely, after the negative pressure is eliminated for 0.1 second, the recovery value and the viscoelastic part value, or called as a plastic part value, of the skin;
ua-the recovery value of the skin from the elimination of the negative pressure to the next successive test of the skin surface plus the negative pressure.
The results are shown in Table 3
Experimental period R2 R5 R7
0 0.4287 0.4063 0.4573
1 0.6345 0.5883 0.6032
2 0.7231 0.6632 0.7678
3 0.8502 0.8096 0.8512
4 0.9231 0.9053 0.9131
As can be seen from table 3, R2, R5, and R7 increased after the first week using the red ginseng original oxygen-activating eye cream prepared in example 1, wherein the values of R2, R5, and R7 approached 1 at week 4, and the skin elasticity index of the subject was greatly improved, and thus, the red ginseng original oxygen-activating eye cream has the effects of increasing skin elasticity and anti-aging.
Experimental example 3:
the eye cream products produced in the early stage of the department are taken as comparative examples, and the red ginseng vigor activating oxygen eye cream products prepared in the examples 1 to 3 and the comparative examples are compared in clinical experiments. The test conditions were: 50 women aged 35-50, 2 times per day, were applied evenly around the eyes, and the skin was recommended to be cleaned and then used for 30 days. The volunteers who felt improved in moisturizing, lightening fine lines and lightening dark circles after the end of the test were compared to, for example, table 4:
table 4:
test items Example 1 Example 2 Example 3 Comparative example
Moisture retention and water retention 80% 82% 88% 60%
Thin lines of desalination 84% 78% 90% 56%
Fading black eye 82% 84% 88% 56%
As can be seen from table 4, compared with the existing products, the red ginseng primordial qi activating oxygen eye cream in the embodiments 1 to 3 of the present invention is successfully qualified in the test items, and the high quality eye cream is realized. Meanwhile, in test items, the effects of moisture retention, fine line fading and dark eye circle fading shown in the examples 1 to 3 of the invention are superior to those of the existing eye cream, and the combined action of the red ginseng and other raw materials is fully exerted. Among them, the best effect is obtained in example 3.

Claims (8)

1. Red ginseng original qi oxygen activating eye cream is characterized in that: the material is prepared from the following raw materials in percentage by weight:
phase A: 31.05-68.43% of water, 4-5% of methyl propylene glycol, 2-5% of glycerol, 0.01-0.05% of hyaluronic acid, 0.01-0.05% of EDTA disodium and 0.1-0.2% of methyl ester; glyceryl polyether-262-5%, PEG/PPG-17/6 copolymer 0.5-3%;
phase B: 2-4% of emulsifier A, 0.5-1% of emulsifier B, 0.5-1% of beeswax, 0.5-1.5% of GMS 30SE, 0.3-1% of 16\18 alcohol, 0.1-0.15% of propyl ester, 0.5-1% of shea butter, 0.5-1% of silicone oil A, 0.5-1% of vitamin E, 3-5% of hydrogenated polydecene, 2-5% of macadamia nut oil, 2-5% of octyldodecanol and 2-5% of silicone oil B;
and C phase: sodium acrylate/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate-801-2%;
phase D: 0.5-2% of red ginseng extract, 0.2-0.5% of carnosine, 1-3% of dipalmitoyl hydroxyproline and 3-6% of water;
phase E: 0.5-2% of glyceryl glucoside, 0.5-2% of chicory tilianin, 0.5-1% of compound anti-allergy agent, 0.05-0.1% of essence and 0.3-0.4% of phenoxyethanol/chlorphenesin.
2. The red ginseng vigor activating oxygen eye cream according to claim 1, wherein: the material is prepared from the following raw materials in percentage by weight:
phase A: 64.01 percent of water, 4 percent of methyl propylene glycol, 2 percent of glycerol, 0.02 percent of hyaluronic acid, 0.02 percent of EDTA disodium and 0.2 percent of methyl ester; glyceryl polyether-263%, PEG/PPG-17/6 copolymer 1%;
phase B: 2.5% of emulsifier A, 0.5% of emulsifier B, 0.8% of beeswax, 1.2% of GMS 30SE, 0.4% of 16\18 alcohol, 0.1% of propyl ester, 0.5% of shea butter, 0.5% of silicone oil A, 0.5% of vitamin E, 3% of hydrogenated polydecene, 2% of macadamia nut oil, 3% of octyldodecanol and 3% of silicone oil B;
and C phase: sodium acrylate/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate-801%;
phase D: 0.6% of red ginseng extract, 0.2% of carnosine, 1% of dipalmitoyl hydroxyproline and 3% of water;
phase E: 0.5 percent of glycerin glucoside, 0.5 percent of chicory tiraparin, 0.5 percent of composite anti-allergy agent, 0.1 percent of essence and 0.35 percent of phenoxyethanol/chlorphenesin.
3. The red ginseng vigor activating oxygen eye cream according to claim 1, wherein: and the silicone oil A in the phase B is polydimethylsiloxane, and the silicone oil B is cyclopenta polydimethylsiloxane/cyclohexasiloxane.
4. The red ginseng vigor activating oxygen eye cream according to claim 1, wherein: beeswax in phase B was beeswax 8044.
5. The red ginseng vigor activating oxygen eye cream according to claim 1, wherein: emulsifier A in phase B is M68 emulsifier, and emulsifier B is A165 emulsifier.
6. The red ginseng vigor activating oxygen eye cream according to claim 1, wherein: the water in phase A and phase D is deionized water.
7. The method for preparing red ginseng vigor activating oxygen eye cream according to any one of claims 1 to 6, comprising the steps of:
step 1: proportioning raw materials of the phase A, the phase B, the phase C, the phase D and the phase E;
step 2: mixing, dispersing and stirring the phase D raw material uniformly to obtain a solution A;
step 2: putting the phase A raw material into a vacuum homogenizing emulsifying pot, starting stirring at the rotating speed of 60rpm, heating to 85-90 ℃, continuously stirring and preserving heat for 5-8min to obtain a solution B;
and step 3: putting the phase B raw material into an oil phase pot, starting stirring at the rotating speed of 40rpm, heating to 80-85 ℃, continuously stirring and preserving heat for 5-8min to completely dissolve the raw material to obtain a solution C;
and 4, step 4: opening the vacuum homogenizing emulsifying pot in the step 2 to vacuum, starting stirring at a rotating speed of 60rpm, pumping the solution C obtained in the step 3 into the vacuum homogenizing emulsifying pot, mixing the solution C with the solution B, opening the vacuum homogenizing emulsifying pot to homogenize at a rotating speed of 2800rpm for 5min, stirring at a rotating speed of 30rpm, keeping the temperature and stirring for 8-10min, and then, starting cooling to obtain a solution D;
and 5: cooling the solution D obtained in the step 4 to 60 ℃, adding the phase C raw material into a vacuum homogenizing emulsifying pot, mixing the phase C raw material with the solution D, starting homogenizing at the rotating speed of 2500rpm for 2min, and continuously stirring and cooling to obtain a solution E;
step 6: cooling the solution E obtained in the step 5 to 45 ℃, then adding the solution A and the E-phase raw material obtained in the step 1, and continuously stirring for 20-30min to obtain a solution F:
and 7: and (4) sampling and detecting the solution F obtained in the step (6), and filtering and discharging after the solution F is qualified.
8. The method for preparing the vigor-activating and oxygen-activating eye cream according to claim 7, wherein the detection in the step 7 comprises appearance detection, viscosity detection, pH value detection, heat resistance detection, cold resistance detection and centrifugation detection.
CN202010954426.6A 2020-09-11 2020-09-11 Red ginseng vigor activating oxygen eye cream and preparation method thereof Pending CN112220714A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010954426.6A CN112220714A (en) 2020-09-11 2020-09-11 Red ginseng vigor activating oxygen eye cream and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010954426.6A CN112220714A (en) 2020-09-11 2020-09-11 Red ginseng vigor activating oxygen eye cream and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112220714A true CN112220714A (en) 2021-01-15

Family

ID=74117064

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010954426.6A Pending CN112220714A (en) 2020-09-11 2020-09-11 Red ginseng vigor activating oxygen eye cream and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112220714A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969444A (en) * 2018-09-19 2018-12-11 陈洁珍 One kind removing black eye, crease-resistant Firm anti-age corrective eye treatment cream and preparation method thereof
CN110302113A (en) * 2019-08-06 2019-10-08 广州珈纳生物科技有限公司 One kind is crease-resistant to remove black eye eye cream
CN111568797A (en) * 2020-04-29 2020-08-25 泉后(广州)生物科技研究院有限公司 Composition for quickly removing fine lines and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969444A (en) * 2018-09-19 2018-12-11 陈洁珍 One kind removing black eye, crease-resistant Firm anti-age corrective eye treatment cream and preparation method thereof
CN110302113A (en) * 2019-08-06 2019-10-08 广州珈纳生物科技有限公司 One kind is crease-resistant to remove black eye eye cream
CN111568797A (en) * 2020-04-29 2020-08-25 泉后(广州)生物科技研究院有限公司 Composition for quickly removing fine lines and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
广东美啦美化妆品股份有限公司: "美肌颜BIOISIS红参元气套盒-红参元气活氧眼霜", 《国产非特殊用途化妆品备案服务平台》 *

Similar Documents

Publication Publication Date Title
CN108670943B (en) Plant extract composition with moisturizing, whitening and spot-lightening functions
CN105147591B (en) A kind of crease-resistant face cream and preparation method thereof
CN111840144B (en) Moisturizing and repairing composition, skin care product and preparation method thereof
CN108969444B (en) Black eye removing, anti-wrinkle firming and repairing eye cream and preparation method thereof
CN111407685A (en) Anti-aging composition of recombinant fibronectin-human-like collagen and preparation method thereof
CN111067840A (en) Polypeptide whitening and repairing wash-free mask
EP3552598A1 (en) Composition containing crocus sativus extract and preparation method and use thereof
CN104042529A (en) Anti-allergic cosmetic composition and preparation method thereof
CN115154375A (en) Stable cleaning composition with repairing and relieving effects
CN110496176A (en) The Chinese medicine health-care emplastrum and preparation method thereof for treating glaucoma and astigmatism
CN117257691A (en) Composition for reducing neck wrinkles, neck mask patch and preparation method thereof
CN111568827A (en) Moisturizing and makeup removing mousse
CN112220714A (en) Red ginseng vigor activating oxygen eye cream and preparation method thereof
CN115364039B (en) Acne skin repair composition and application thereof
CN106511253A (en) Whitening and moisturizing facial mask cream and preparation method thereof
CN110522662A (en) A kind of ganoderma lucidum face cream and preparation method thereof
CN110025558B (en) Soybean polysaccharide-rich amino acid nano facial cleanser and preparation method thereof
CN108078906B (en) Tea oil hair mask for hair waving and dyeing and preparation method and application thereof
CN114306194A (en) Freckle-removing cosmetic composition containing umbilical cord blood extract, freckle-removing cream and preparation method thereof
CN113712894A (en) Essence emulsion composition with moisturizing and relieving effects and preparation method and application thereof
CN109010105B (en) Multi-effect composition and preparation method and application thereof
CN112137947A (en) Preparation method of special-effect high-moisture-retention emulsion
CN108721174A (en) A kind of anti-aging skin care product and preparation method thereof of addition Fructus Cannabis extract
CN115089539B (en) Skin tightening plant extract composition and preparation method and application thereof
CN110538087A (en) Polypeptide tightening and lifting face cream

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210115

RJ01 Rejection of invention patent application after publication